FDAnews
www.fdanews.com/articles/85036-escorpion-azul-s-a-has-joined-forces-with-labiofam

ESCORPION AZUL, S.A. HAS JOINED FORCES WITH LABIOFAM

March 6, 2006

Escorpion Azul, S.A. invests in Cuba's Labiofam to aid in the clinical and controlled development of Escozul. While Escozul was first developed in Cuba in the early 1980's by biologist Misael Bordier from Guantanamo, it remains under intense study. The popularity of Escozul as an alternative "medicine" in the treatment of a variety of cancers has grown to epic proportions as cancer patients and family members worldwide have sought out this potential "miracle" cure. Escozul extract is obtained from a species of blue scorpion known as Rhopalurus junceus. It is normally diluted with purified water before being administered.

Keralanext (http://www.keralanext.com/news/index.asp?id=601444)